Evidence map›Paper›PMID 39171087›Full record

ArticleBiochemia medica2024

D-dimer assay interference detected by the discrepancy in D-dimer concentrations at different dilutions: a case report.

Marija Milić, Dejana Brkić Barbarić, Iva Lukić, Mirna Kirin, Vikica Buljanović, Vatroslav Šerić

Abstract readCase Reports
In one paragraph

Article in Biochemia medica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marija MilićClinical Institute of Laboratory Diagnostics, University Hospital Centre Osijek, Osijek, Croatia.
Dejana Brkić BarbarićClinical Institute of Transfusion Medicine, University Hospital Centre Osijek, Osijek, Croatia.
Iva LukićClinical Institute of Laboratory Diagnostics, University Hospital Centre Osijek, Osijek, Croatia.
Mirna KirinSiemens Healthineers, Siemens Healthcare d.o.o, Zagreb, Croatia.
Vikica BuljanovićMedical Biochemistry Laboratory, General Hospital Našice, Našice, Croatia.
Vatroslav ŠerićClinical Institute of Laboratory Diagnostics, University Hospital Centre Osijek, Osijek, Croatia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case report describes interference from heterophilic antibodies in D-dimer assay. The interference was suspected due to discrepancies between D-dimer concentrations in the original sample and diluted samples, as well as inconsistent clinical findings. The patient's medical history, laboratory results, and imaging studies were considered in the investigation. Heterophilic antibodies, likely developed during the SARS-CoV-2 infection, were identified as the probable cause of interference. The interference was confirmed through various methods, including dilution studies, blocking heterophilic antibodies, and comparing results with an alternative D-dimer method. This case highlights the importance of recognizing and addressing interference in D-dimer testing, emphasizing the need for collaboration between clinicians and laboratory specialists.

Indexed as

COVID-19Fibrin Fibrinogen Degradation ProductsSARS-CoV-2Antibodies, HeterophileFemaleHumansMaleAntibodies, HeterophileFibrin Fibrinogen Degradation Productsfibrin fragment Dblood coagulation testsD-dimerheterophile antibodiesinterference

Identifiers

PMID39171087
PMCPMC11334198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.